Elanco Animal Health Inc 4

Director-level insider Paul Herendeen purchased 10,000 shares of Elanco Animal Health Inc. common stock at about $23.685 per share, increasing his direct holdings to 111,687 shares.

On August 7, 2026, insider Paul Herendeen acquired 10,000 shares of Elanco Animal Health Inc. common stock in an open-market purchase at an average price of approximately $23.685 per share, for a total cost of about $236,850. Following this transaction, his direct ownership increased to 111,687 shares, implying a post-transaction holding value of roughly $2.54 million based on the reported transaction price (or about $2.54 million using the current market price as a close proxy), signaling a meaningful personal capital commitment to the company’s stock.

Filing Facts

CIK

1739104

Ticker

ELAN

Form

4

Source Type

fda

Accession

0001374175-26-000005

Alert Tier

7